Prestige Consumer Healthcare PBH
NYSE PBH
$51.31 +0.79 (+1.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025)

Prestige Consumer Healthcare (PBH) posted quarterly Change in Account Payables of -$4.1 million for Q4 2025, up 63.68% year-over-year from -$2.5 million in Q4 2024, and down 120.66% quarter-over-quarter from $19.8 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$4.1 million for Q4 2025.

  • In Q4 2025, Change in Account Payables rose 63.68% year-over-year to -$4.1 million; the TTM figure through Dec 2025 stood at $17.9 million (up 190.12% YoY), while the FY2025 annual figure was -$19.4 million, up 22.27% from the prior year.
  • Change in Account Payables for Q4 2025 stood at -$4.1 million, down from $19.8 million in the prior quarter.
  • The five-year high for Change in Account Payables was $19.8 million in Q3 2025, with the low at -$15.6 million in Q2 2021.
  • The 5-year median for Change in Account Payables is -$783500.0 (2024), against an average of $446700.0.
  • The sharpest annual moves came in 2023 and 2025: Change in Account Payables slumped 766.38% in 2023, then surged 366.33% in 2025.
  • Prestige Consumer Healthcare's Change in Account Payables stood at $2.2 million in 2021, then surged by 258.65% to $7.9 million in 2022, then plunged by 165.31% to -$5.1 million in 2023, then slumped by 118.8% to -$11.3 million in 2024, then jumped by 63.68% to -$4.1 million in 2025.
  • Business Quant data shows PBH's Change in Account Payables at -$4.1 million in Q4 2025, $19.8 million in Q3 2025, and $2.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Prestige Consumer Healthcare 2.46 Bn 2.39 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.09 Mn
Dec 31, 2025 -4.09 Mn
Sep 30, 2025 19.79 Mn
Sep 30, 2025 19.79 Mn
Jun 30, 2025 2.76 Mn
Jun 30, 2025 2.76 Mn
Mar 31, 2025 -560,000.00
Mar 31, 2025 -560,000.00
Dec 31, 2024 -11.26 Mn
Dec 31, 2024 -11.26 Mn
Sep 30, 2024 -8.19 Mn
Sep 30, 2024 -8.19 Mn
Jun 30, 2024 591,000.00
Jun 30, 2024 591,000.00
Mar 31, 2024 -1.01 Mn
Mar 31, 2024 -1.01 Mn
Dec 31, 2023 -5.14 Mn
Dec 31, 2023 -5.14 Mn
Sep 30, 2023 -13.22 Mn
Sep 30, 2023 -13.22 Mn